SANUWAVE Health, Inc.
SANUWAVE Health, Inc.
Your view on SNWV
Overview
What the company does, where it operates, and who runs it.
About SANUWAVE Health, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Morgan C. Frank
- Headquarters
- 3360 Martin Farm Road, Suwanee, GA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Morgan C. Frank
- Headquarters
- 3360 Martin Farm Road, Suwanee, GA, US
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.
Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers.
Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration.
The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions.
In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures.
The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for SANUWAVE Health, Inc. from FRC's valuation model, read against the market price. SNWV last traded at $1.71, 5.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for SANUWAVE Health, Inc.. Starting points for SANUWAVE Health, Inc.: P/E 5.5, EPS $0.30, beta 1.48 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for SANUWAVE Health, Inc.. Trailing twelve-month EPS for SANUWAVE Health, Inc. stands at $0.30. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$54.00
average of analysts' targets
Analyst Ratings
- Strong Buy0
- Buy2
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $0.07 | $0.29 | -$0.08 | $0.37 |
| Low estimate | $0.07 | $0.29 | -$0.08 | $0.37 |
| High estimate | $0.07 | $0.29 | -$0.08 | $0.37 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | $0.031 | -$0.17 | $0.411 | — |
| Growth | — | +271.2% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $16.50M | $8.10M | $51.35M | $64.50M |
| Low estimate | $16.50M | $8.10M | $51.35M | $64.50M |
| High estimate | $16.50M | $8.10M | $51.35M | $64.50M |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | $13.09M | $9.62M | $44.05M | — |
| Growth | +26.0% | -15.8% | +16.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- FHTXFoghorn Therapeutics Inc.Biotechnology$107M
- HSDTSolana CompanyAsset Management$95M
- IMRXImmuneering CorporationBiotechnology$227M
- INGNInogen, Inc.Medical - Devices$145M
- MASS908 Devices Inc.Medical - Specialties$396M
- NNOXNano-X Imaging Ltd.Medical - Devices$21M
- OMOutset Medical, Inc.Medical - Devices$57M
- QTRXQuanterix CorporationMedical - Devices$98M
More Medical - Devices companies
- NHNKYNihon Kohden CorporationOTC$3.7B
- NMRDNemaura Medical Inc.OTC$404
- NMTCNeuroOne Medical Technologies CorporationNASDAQ$7M
- NPCENeuroPace, Inc.NASDAQ$283M
- NSPRInspireMD, Inc.NASDAQ$32M
- NSYSNortech Systems IncorporatedNASDAQ$33M
- NUMDNu-Med Plus, Inc.OTC$1M
- NUWENuwellis, Inc.NASDAQ$353,130
- NVCRNovoCure LimitedNASDAQ$1.3B
- NVNOenVVeno Medical CorporationNASDAQ$4M
- NWCINewCardio, Inc.OTC$3,315
ETFs holding SANUWAVE Health, Inc.
% of the fund
- VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
- VXFVanguard Extended Market ETF$30.2B in assets0.00%
- QQQSInvesco NASDAQ Future Gen 200 ETF$20M in assets0.22%
- IWCiShares Micro-Cap ETF$1.2B in assets0.00%
- VUN.TOVanguard U.S. Total Market Index ETF$20.1B in assets0.00%
Largest holders first, then the funds most concentrated in SNWV.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold SANUWAVE Health, Inc., and how their positions are changing. At a $14.7M market value, institutional positions materially move SANUWAVE Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by SANUWAVE Health, Inc. executives and directors. Shares of SANUWAVE Health, Inc. have traded between $18.50 and $46.59 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for SANUWAVE Health, Inc.. Coverage tracks SANUWAVE Health, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of SANUWAVE Health, Inc.